Oculis Holding AG (OCS) Other Working Capital Changes (2022 - 2025)
Oculis Holding AG (OCS) recorded quarterly Other Working Capital Changes of -$605566.2 in Q4 2025, down 134.28% quarter-over-quarter from $1.8 million in Q3 2025, and up 44.8% on a YoY basis from -$418214.2 in Q4 2024.
Oculis Holding AG (OCS) Other Working Capital Changes (2022 - 2025) Analysis & Trends
Oculis Holding AG's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$605566.2 for Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 44.8% year-over-year to -$605566.2; the TTM figure through Dec 2025 stood at $2.9 million (down 49.71% YoY), while the FY2025 annual figure was $2.9 million, down 48.31% from the prior year.
- Other Working Capital Changes was -$605566.2 for Q4 2025 at Oculis Holding AG, down from $1.8 million in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $4.7 million in Q1 2024 to a low of -$3.3 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged $8670.5 across 4 years, with a median of -$36030.4 in 2022.
- The sharpest annual moves came in 2023 and 2024: Other Working Capital Changes sank 2142.34% in 2023, then surged 4561.45% in 2024.
- A 4-year view of Other Working Capital Changes shows it stood at -$2.2 million in 2022, then grew by 25.77% to -$1.6 million in 2023, then soared by 32.33% to -$1.1 million in 2024, then jumped by 44.8% to -$605566.2 in 2025.
- The last three Other Working Capital Changes figures came in at -$605566.2 (Q4 2025), $1.8 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Oculis Holding AG | 8.23 Bn | 7.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -605,566.18 |
| Dec 31, 2025 | -605,566.18 |
| Sep 30, 2025 | 1.77 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Jun 30, 2025 | 1.72 Mn |
| Mar 31, 2025 | -8,898.00 |
| Mar 31, 2025 | -8,898.00 |
| Dec 31, 2024 | -1.10 Mn |
| Dec 31, 2024 | -1.10 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Sep 30, 2024 | 1.96 Mn |
| Jun 30, 2024 | 121,637.28 |
| Jun 30, 2024 | 121,637.28 |
| Mar 31, 2024 | 4.74 Mn |
| Mar 31, 2024 | 4.74 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Dec 31, 2023 | -1.62 Mn |
| Sep 30, 2023 | -1.42 Mn |
| Sep 30, 2023 | -1.42 Mn |